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INTRODUCTION
The  Mitral  Valve  Prolapse  syndrome  has  been  recognized  as  one  of 
the most  prevalent  cardiac  valvular  abnormalities  affecting  5  –  10% of  the  
population.  In  majority  of  the  patients  with  Mitral  Valve  Prolapse,  the 
cause  is  unknown.  The  overwhelming  majority  of  the  patients  are 
asymptomatic.
The  clinical  presentation  of  Mitral  Valve  Prolapse  is  also  diverse.  
They  present  with  a  variety  of  symptoms  such  as  fatigability,  palpitation,  
postural  giddiness  and  neuro  psychiatric  symptoms  of  autonomic 
dysfunction.  Patients  with  Mitral  Valve  Prolapse  may  have  a  variety  of 
cardiac and non cardiac abnormalities in addition to valvular lesion with its  
midsystolic  click  and  murmur.  This  includes  skeletal  abnormalities  like  
scoliosis,  straight  back  syndrome,  Pectus  excavatum  and  asthenic  build, 
abnormal  cardiovascular  and  electrocardiographic  responses  to  exercise,  
ST-T  changes  in  resting  ECG  and  a  variety  of  Atrial  and  ventricular  
arrhythmias.
Wooley  reported  clinical  similarities  between  Mitral  Valve  Prolapse 
and Da Costa  syndrome,  vasoregulatory asthenia  described by Holmgren et 
al and hyperkinetic heart syndrome reported by Gorlin.
The presence of chest pain, ST-T abnormalities and arrhythmias in the 
absence  of  hemodynamically  significant  valvular,  myocardial  or  coronary 
arterial  disease  suggests  the  possibility  of  a  disorder  involving  autonomic 
system.  Greater  attention  and  enthusiasm  on  this  condition  has  been 
developed  because  of  high  prevalence  of  the  condition  and  increased  risk  
of  sudden  death.  Since  special  therapeutic,  prognostic  and  genetic  factors 
must  be  considered  in  Mitral  Valve  Prolapse  syndrome,  precise 
identification of the condition is essential.
AIM OF THE STUDY
The  Aim of  this  study  is  to  study  the  clinical  profile  of  Mitral  Valve  
Prolapse  Syndrome  and  investigating  the  existence  of  Autonomic 
Dysfunction in the subjects studied through bedside tests.
REVIEW OF LITERATURE
Mitral  Valve  Prolapse  Syndrome,  also  variously  termed  the  systolic 
click-murmur  syndrome,  Barlow's  syndrome,  floppy-valve  syndrome,  and 
billowing Mitral  leaflet  syndrome ,  myxomatous mitral  valve syndrome and 
redundant  cusp  syndrome.  [ 1 ] This  is  a  relatively  common,  but  highly 
variable  clinical  syndrome  resulting  from  diverse  pathogenic  mechanisms 
of the mitral valve apparatus. The Mitral Valve Prolapse syndrome is one of  
the  most  prevalent  cardiac  valvular  abnormalities.  It  results  from  diverse 
pathogenic  mechanisms  of  one  or  more  portions  of  the  mitral  valve 
apparatus,  valve  leaflets,  chordae  tendineae,  papillary  muscle,  and  valve  
annulus. Among these is excessive or redundant mitral leaflet tissue, which  
is  commonly  associated  with  myxomatous  degeneration  and  greatly 
increased concentrations of acid mucopolysaccharide. 
Using  standardized  echocardiographic  diagnostic  criteria,  a 
community-based  study  showed  that  Mitral  Valve  Prolapse  syndrome 
occurs  in  2.4  percent  of  the  population.  [4 ] Mitral  Valve  Prolapse  is  a 
frequent  finding  in  patients  with  heritable  disorders  of  connective  tissue,  
including  the  Marfan  syndrome,  Osteogenesis  imperfecta,  and  the  Ehler-
Danlos  syndrome.  In  most  patients  with  Mitral  Valve  Prolapse,  however, 
myxomatous  degeneration  is  confined  to  the  mitral  (or  less  commonly  the  
tricuspid  or  aortic)  valves  without  other  clinical  or  pathologic 
manifestations  of  disease.  The  posterior  leaflet  is  usually  more  affected  
than  the  anterior,  and  the  mitral  valve  annulus  is  often  greatly  dilated.  In  
many  patients,  elongated  redundant  chordae  tendineae  cause  or  contribute 
to the regurgitation.
Most  frequently,  Mitral  Valve  Prolapse  occurs  as  a  primary condition 
that  is  not  associated  with  other  diseases  and  can  be  familial  or  non 
familial.  Familial  Mitral  Valve  Prolapse  is  transmitted  as  an  autosomal 
trait,  and several  chromosomal  loci  have  been identified.  The Mitral  Valve  
Prolapse  syndrome  is  more  prevalent  in  young  women,  [12 ] who  generally 
have a benign course, whereas severe myxomatous disease is more common 
in  older  men,  who have a  higher  risk  of  complications,  including the  need  
for  surgical  Mitral  Valve  repair.  Mitral  Valve  Prolapse  has  also  been 
associated  with  many  conditions,  occurring  quite  commonly  in  heritable 
disorders  of  connective  tissue  that  increase  the  size  of  the  mitral  leaflets  
and apparatus.
Echocardiographic evidence of Mitral Valve Prolapse is found in most 
patients  with  the  Marfan  syndrome  and  in  many  of  their  first-degree 
relatives.  Mitral  Valve  Prolapse  has  also  been  associated  with  Ehlers-
Danlos  syndrome,  Osteogenesis  imperfecta,  pseudoxanthoma  elasticum,  
periarteritis  nodosa,  myotonic  dystrophy,  Von  Willebrand  disease, 
hyperthyroidism, and congenital  malformations such as Ebstein anomaly of  
the tricuspid valve, Atrial septal defect of the ostium secundum variety, the  
Holt-Oram  syndrome,  and  Hypertrophic  Cardiomyopathy.  There  may  be  a 
higher  incidence  of  Mitral  Valve  Prolapse  in  patients  with  an  asthenic  
habitus  and  various  congenital  thoracic  deformities,  including  “straight 
back syndrome,” pectus excavatum, and a shallow chest. These associations 
have  not  been  proved  using  rigorous  echocardiographic  criteria,  and,  with  
the  exception  of  connective  tissue  disorders,  it  is  not  clear  how  many  of  
these are chance associations. [33 ]
Mitral Valve Prolapse Syndrome
Younger age (20-50 yr)
Predominantly female
Click or click-murmur on physical examination
Thin leaflets with systolic displacement on echocardiography
Associated with low blood pressure, orthostatic
Hypotension, palpitations
Benign long-term course
Myxomatous Mitral Valve Disease
Older age (40-70 yr) 
Predominantly male
Thickened, redundant valve leaflets
Mitral regurgitation on physical exam and echocardiography
High likelihood of progressive disease requiring mitral valve surgery
Secondary Mitral Valve Prolapse
Marfan syndrome
Hypertrophic cardiomyopathy
Ehlers-Danlos syndrome
Other connective tissue diseases.
In  most  patients  with  Mitral  Valve  Prolapse,  the  cause  is  unknown,  
but  in  some  it  appears  to  be  a  genetically  determined  collagen  tissue 
disorder.  A  reduction  in  the  production  of  type  III  collagen  has  been 
incriminated,  and  electron  microscopy  has  revealed  fragmentation  of 
collagen  fibrils.  Mitral  Valve  Prolapse  may  be  associated  with  thoracic 
skeletal  deformities  similar  to  but  not  as  severe  as  those  in  the  Marfan  
syndrome,  including  a  high-arched  palate  and  alterations  of  the  chest  and 
thoracic  spine,  including  the  so-called  straight  back  syndrome.  Mitral  
Valve  Prolapse  also  may  occur  as  a  sequel  of  acute  rheumatic  fever,  in 
ischemic  heart  disease,  and  in  cardiomyopathies,  as  well  as  in  20%  of  
patients with ostium secundum Atrial septal defect.
Mitral  Valve  Prolapse  may  lead  to  excessive  stress  on  the  papillary 
muscles,  which  in  turn  leads  to  dysfunction  and  ischemia  of  the  papillary  
muscles  and  the  subjacent  ventricular  myocardium.  Rupture  of  chordae 
tendineae  and  progressive  annular  dilatation  and  calcification  also 
contribute  to  valvular  regurgitation,  which  then  places  more  stress  on  the 
diseased  mitral  valve  apparatus,  thereby  creating  a  vicious  circle.  The 
electrocardiographic  changes  and  ventricular  arrhythmias  appear  to  result  
from regional  ventricular  dysfunction  related  to  increased  stress  placed on  
the papillary muscles.
Recent  studies  have  found  a  direct  role  of  rheumatic  Mitral  stenosis  
in the genesis of secondary Mitral valve prolapse.
GENETICS
New  locus  for  autosomal  dominant  Mitral  valve  prolapse  has  been 
mapped to chromosome 13, in recent studies. [1 3]
 PATHOLOGY
Findings  include  myxomatous  proliferation  of  the  Mitral  valve 
leaflets,  in  which  the  spongiosa  component  of  the  valve  (i.e.,  the  middle  
layer  of  the  leaflet  between  the  atrialis  and  the  ventricularis  composed  of  
loose,  myxomatous  material)  is  unusually  prominent  and  the  quantity  of  
acid  mucopolysaccharide  is  increased  Electron  microscopy  shows  a 
haphazard  arrangement  of  cells  with  disruption  and  with  fragmentation  of  
collagen  fibrils.  Secondary  effects  include  fibrosis  of  the  surface  of  the  
Mitral  Valve  leaflets,  thinning  and/or  elongation  of  the  chordae  tendineae,  
and ventricular friction lesions.
In mild  cases,  the valvular  myxoid  stroma is  enlarged on histological  
examination,  but  the leaflets  are  grossly  normal.  However,  with increasing 
quantities  of  myxoid  stroma,  the  leaflets  become  grossly  abnormal, 
redundant,  and  prolapsed.  There  is  interchordal  hooding  due  to  leaflet  
redundancy  that  includes  both  the  rough  and  clear  zones  of  the  involved 
leaflets.  Regions  of  endothelial  disruption  are  common  and  are  possible  
sites  of  endocarditis  or  thrombus  formation.  The  severity  of  Mitral 
Regurgitation  depends  on  the  extent  of  the  prolapse.  The  cusps  of  the 
mitral valve, the chordae tendineae, and the annulus may all  be affected by  
myxomatous  proliferation.  Degeneration  of  collagen  and  myxomatous 
changes  within  the  central  core  of  the  chordae  tendineae,  with  associated  
decreases in tensile  strength,  are primarily responsible for  chordal  rupture,  
which often  occurs  and may  intensify  the  severity  of  Mitral  Regurgitation.  
Increased  chordal  tension  resulting  from  the  enlarged  area  of  the  valve  
cusps  may  play  a  contributory  role.  Myxomatous  changes  in  the  annulus 
may result  in  annular  dilation and calcification,  further  contributing to  the  
severity of Mitral Regurgitation.
Myxomatous  proliferation,  although  most  commonly  affecting  the 
mitral  valve,  has also been described in the tricuspid,  aortic,  and pulmonic  
valves,  particularly in patients  with the Marfan syndrome,  and may lead to 
regurgitation of these valves as well as the mitral valve.
CLINICAL FEATURES
Mitral  Valve  Prolapse  is  more  common  in  females.  It  affects 
individuals in a wide age range but most  commonly those between the ages  
of  14  and  30  years.  However,  serious  Mitral  Regurgitation  occurs  more  
frequently in older  males (older  than 50 years)  with Mitral  Valve Prolapse,  
than in young females with this disorder, and requires surgical treatment.
The  clinical  course  is  often  benign.  Mitral  Valve  Prolapse 
encompasses  a  broad  spectrum  of  severities,  ranging  from  only  a  systolic  
click  and  murmur  and  mild  prolapse  of  the  posterior  leaflet  of  the  mitral  
valve  to  severe  Mitral  Regurgitation  due  to  chordal  rupture  and  massive 
prolapse  of  both  leaflets.  In  many  patients,  this  condition  progresses  over  
years or decades.
Most  patients  are  asymptomatic  and  remain  so  for  their  entire  lives.  
However,  Mitral  Valve Prolapse is  now the most  common cause of  isolated 
severe  Mitral  Regurgitation requiring  surgical  treatment  in  North  America.  
Early studies called attention to a “Mitral Valve Prolapse syndrome” with a  
characteristic  systolic  non  ejection  click  and  various  nonspecific 
symptoms,  such  as  fatigability,  palpitations,  postural  hypotension,  and 
anxiety  and  other  neuropsychiatric  symptoms,  as  well  as  symptoms  of 
autonomic dysfunction. Arrhythmias, most commonly ventricular premature 
contractions  and  paroxysmal  supraventricular  and  ventricular  tachycardia,  
have  been  reported  and  may  cause  palpitations,  light-headedness,  and 
syncope.  Sudden  death  is  a  very  rare  complication.  [6 ]  Many  patients  have 
chest  pain  that  is  difficult  to  evaluate.  It  is  often  substernal,  prolonged,  
poorly  related  to  exertion,  and  rarely  resembles  angina  pectoris.  The 
discomfort  may be  secondary  to  abnormal  tension on papillary  muscles.  In 
patients  with  Mitral  Valve  Prolapse  and  severe  Mitral  Regurgitation,  the 
symptoms  of  the  latter  (fatigue,  dyspnea,  and  exercise  limitation)  may  be 
present.  Transient  cerebral  ischemic  attacks  secondary  to  emboli  from the 
mitral  valve  due  to  endothelial  disruption  have  been  reported.  Infective  
endocarditis  may  occur  in  patients  with  Mitral  Regurgitation  associated  
with Mitral Valve Prolapse.
The body weight is often low, and the habitus may be asthenic. Blood  
pressure  is  usually  normal  or  low;  orthostatic  hypotension may be  present.  
As  already  mentioned,  patients  with  Mitral  Valve  Prolapse  have  a  higher 
than  expected  prevalence  of  “straight  back  syndrome,”  scoliosis,  and 
pectus  excavatum.  Mitral  Regurgitation  ranges  from absent  to  severe.  The 
clinical  and  echocardiographic  criteria  for  the  diagnosis  of  Mitral  Valve  
Prolapse have been well established.
Mitral  Valve  Prolapse  during  pregnancy  is  frequent,  it  accounts  for  
8.3%.  Varies  symptomatology  was  characteristic  for  all  the  groups  with 
Mitral  Valve  Prolapse.  The  most  frequent  complaints  were:  dizziness,  
palpitation,  and  faintness.  Women  with  Mitral  Valve  Prolapse  are  not 
protected by pregnancy.
The  incidence  of  benign  joint  hyper  mobility  syndrome  (BJHMS)  in 
patients  with  Mitral  Valve  Prolapse  was  more  frequent  than  the  normal  
population  and  there  was  a  significant  correlation  between  the  severity  of 
Benign  Joint  Hyper  Mobility  Syndrome  (according  to  BHS)  and 
echocardiographic   features  of  the  mitral  leaflets  and elastic  properties  of  
the aortic wall . [14]
AUSCULTATION
The characteristic  systolic  click  and mid-to-late  systolic  murmur  is  a  
major  diagnostic  criterion.  The  auscultatory  findings  unique  to  the  Mitral  
Valve  Prolapse  syndrome  are  best  elicited  with  the  diaphragm  of  the 
stethoscope.  The  patient  should  be  examined  in  the  supine,  left  decubitus,  
and sitting positions.  The most  important  finding is  a non ejection systolic  
click  at  least  0.14  second  after  S1.  This  can  be  differentiated  from  a  
systolic  ejection  click  because  it  occurs  after  the  beginning  of  the  carotid  
pulse  upstroke.  Occasionally,  multiple  mid  and  late  systolic  clicks  are 
audible,  most  readily  along  the  lower  left  sternal  border.  The  clicks  are  
believed  to  be  produced  by  sudden  tensing  of  the  elongated  chordae  
tendineae  and  of  the  prolapsing  leaflets.  They  are  often,  although  not  
invariably,  followed  by  a  mid-  to  late  crescendo  systolic  murmur  that  
continues  to  A2.  This  murmur  is  similar  to  that  produced  by  papillary 
muscle  dysfunction,  which  is  readily  understandable  because  both  result  
from mid-  to  late  systolic  Mitral  Regurgitation.  In  general,  the duration  of 
the murmur is  a  function of  the severity  of  the Mitral  Regurgitation.  When  
the murmur is confined to the latter portion of systole, Mitral Regurgitation 
usually  is  not  severe.  However,  as  Mitral  Regurgitation  becomes  more 
severe,  the  murmur  commences  earlier  and  ultimately  becomes 
holosystolic.
There is considerable variability of the physical findings in the Mitral 
Valve  Prolapse  syndrome.  Some  patients  exhibit  both  a  midsystolic  click  
and  a  mid-to-late  systolic  murmur;  others  present  with  only  one  of  these 
two  findings;  still  others  have  only  a  click  on  one  occasion  and  only  a 
murmur  on another,  both on a  third examination,  and no abnormality  at  all  
on  a  fourth.  Conditions  other  than  Mitral  Valve  Prolapse  that  may  cause  
midsystolic  clicks  include  tricuspid  valve  prolapse,  Atrial  septal  
aneurysms, and extra cardiac causes.
DYNAMIC AUSCULTATION
The  auscultatory  findings  are  exquisitely  sensitive  to  physiological 
and pharmacological  interventions,  and recognition of  the changes induced 
by these interventions is of great value in the diagnosis of the Mitral Valve  
Prolapse syndrome. The mitral valve begins to prolapse when the reduction 
of  Left  Ventricular  volume during systole  reaches  a  critical  point  at  which 
the  valve  leaflets  no  longer  coapt;  at  that  instant,  the  click  occurs  and  the  
murmur commences. Any maneuver that decreases Left Ventricular volume,  
such as a reduction of impedance to Left Ventricular outflow, a reduction in 
venous return,  tachycardia,  or  an augmentation of  myocardial  contractility, 
results  in  an  earlier  occurrence  of  prolapse  during  systole.  As  a  
consequence,  the  click  and  onset  of  the  murmur  move  closer  to  S1.  When 
prolapse  is  severe  and/or  Left  Ventricular  size  is  markedly  reduced,  
prolapse  may  begin  with  the  onset  of  systole.  As  a  consequence,  the  click  
may  not  be  audible,  and  the  murmur  may  be  holosystolic.  On  the  other  
hand,  when  Left  Ventricular  volume  is  augmented  by  an  increase  in  the 
impedance  to  Left  Ventricular  emptying,  an  increase  in  venous  return,  a  
reduction of myocardial contractility, or bradycardia, both the click and the 
onset of the murmur will be delayed.
During the straining phase of the Valsalva maneuver and upon sudden  
standing,  cardiac  size  decreases,  and  both  the  click  and  the  onset  of  the  
murmur  occur  earlier  in  systole.  In  contrast,  a  sudden  change  from  the 
standing  to  the  supine  position,  leg-raising,  squatting,  maximal  isometric  
exercise,  and,  to  a  lesser  extent,  expiration  will  delay  the  click  and  the  
onset  of  the murmur.  During the overshoot  phase of  the Valsalva maneuver  
(i.e.,  six  to eight  cycles following release)  and with prolongation of  the R-
R  interval,  either  following  a  premature  contraction  or  in  Atrial  
Fibrillation,  the  click  and  onset  of  the  murmur  are  usually  delayed,  or  the  
intensity  of  the  murmur  is  reduced.  Maneuvers  that  elevate  arterial 
pressure,  such as isometric exercise,  increase the intensity  of  the click and 
murmur.  In  general,  when  the  onset  of  the  murmur  is  delayed,  both  its 
duration and intensity are diminished, reflecting a reduction in the severity  
of Mitral Regurgitation.
The  response  to  several  interventions  may  be  helpful  in 
differentiating obstructive Hypertrophic Cardiomyopathy from Mitral Valve 
Prolapse.  During  the  strain  of  the  Valsalva  maneuver,  the  murmur  of 
Hypertrophic  Cardiomyopathy  increases  in  intensity,  whereas  the  murmur 
of  Mitral  Valve  Prolapse  becomes  longer  but  usually  not  louder.  The 
murmur of Hypertrophic Cardiomyopathy becomes louder after amyl nitrite 
inhalation,  whereas  that  of  Mitral  Valve  Prolapse  does  not.  Following  a  
premature  beat,  the  murmur  of  Hypertrophic  Cardiomyopathy  increases  in 
intensity  and  duration,  whereas  that  due  to  Mitral  Valve  Prolapse  usually  
remains unchanged or decreases.
LABORATORY EXAMINATION
ELECTROCARDIOGRAM:
The  Electrocardiogram  most  commonly  is  normal  but  may  show 
biphasic  or  inverted  T  waves  in  leads  II,  III,  and  aVF,  and  occasionally  
supraventricular or ventricular premature contractions.
ECHOCARDIOGRAPHY:
Echocardiography  plays  an  essential  role  in  the  diagnosis  of  Mitral 
Valve  Prolapse  and  has  been  instrumental  in  the  delineation  of  this 
syndrome.  To establish the diagnosis,  the two-dimensional  echocardiogram 
must  show  that  one  or  both  mitral  valve  leaflets  billow  by  at  least  2  mm 
into the left  atrium during systole  in  the long-axis  view.  Thickening of  the  
involved  leaflet  to  greater  than  5  mm  supports  the  diagnosis.  Findings  of 
more  severe  myxomatous  disease  include  increased  leaflet  area,  leaflet  
redundancy,  chordal  elongation,  and  annular  dilation.  These  findings  are  
also helpful in identifying patients at significant risk for developing severe 
Mitral  Regurgitation or  infective  endocarditis.  The mitral  annular  diameter 
is often abnormally increased. 
Systolic pulmonary venous flow reversal identified by pulsed Doppler 
echocardiography is useful  for  the diagnosis  of severe mitral  regurgitation.  
The  direction  of  the  mitral  regurgitant  jet  in  severe  mitral  regurgitation 
significantly influences the systolic pulmonary venous flow reversal,  using 
transthoracic color Doppler echocardiography. [1 8]
In  one  Study,  additional  diagnostic  criteria  were  searched.  It  was 
found  that  in  patients  with  Mitral  Valve  Prolapse,  the  main  pulmonary 
artery  diameter  was  significantly  larger  (>23  mm)  in  patients  with  Marfan  
Syndrome at all ages when compared with controls. [11]
Transesophageal  echocardiography  provides  additional  details 
regarding  integrity  of  the  mitral  valve  apparatus,  such  as  rupture  of  
chordae  tendineae.  In  Mitral  Regurgitation  secondary  to  Mitral  Valve 
Prolapse,  the echocardiogram also provides valuable information regarding  
Left Ventricular size and function. 
The  echocardiographic  findings  of  Mitral  Valve  Prolapse  may  be 
observed  in  patients  without  a  click  or  murmur.  Others  have  both  the  
typical echocardiographic and auscultatory features. 
Buckling  of  the  mitral  valve,  as  seen  from  the  short  axis  views, 
appears to provide a confirmatory role in diagnosing mitral  valve prolapse,  
particularly in questionable cases; improving the overall accuracy. [16 ]
The  echocardiographic  findings  of  Mitral  Valve  Prolapse  have  been 
reported  to  occur  in  a  large  number  of  first-degree  relatives  of  patients 
with established Mitral Valve Prolapse.  Two-dimensional  echocardiography 
has  also  revealed  prolapse  of  the  tricuspid  and  aortic  valves  in 
approximately  20  percent  of  patients  with  Mitral  Valve  Prolapse.  [7 ] 
Conversely,  however,  prolapse  of  the  tricuspid  and  aortic  valves  occurs  
uncommonly in patients without prolapse of the mitral valve.
Doppler  echocardiography  frequently  reveals  mild  Mitral 
Regurgitation  that  is  not  always  associated  with  an  audible  murmur.  
Moderate  to  severe  Mitral  Regurgitation  is  present  in  about  two-thirds  of 
patients  with  posterior  leaflet  prolapse  and in  about  one-fourth  of  patients  
with  anterior  leaflet  prolapse.  Severity  of  Mitral  Regurgitation  should  be 
assessed  quantitatively  as  previously  discussed.  Studies  in  Department  of  
Cardiovascular  Hemodynamics,  Osaka  City  University  Medical  School 
Hospital,  Osaka,  indicate  that  freehand  3D echocardiography  is  useful  for  
assessment of the involved lesion of the mitral valve in patients with mitral  
valve prolapse.  [ 15 ]
ARRHYTHMIAS
Spectrums of  arrhythmias  have  been observed in  patients  with  Mitral  
Valve Prolapse. These include Atrial and ventricular premature contractions  
and  supraventricular  and  ventricular  tachyarrhythmias,  as  well  as 
bradyarrhythmias  due  to  sinus  node  dysfunction  or  varying  degrees  of 
atrioventricular  block.  The  mechanism  of  the  arrhythmias  is  not  clear.  [2 2] 
Diastolic  depolarization  of  muscle  fibres  in  the  anterior  mitral  leaflet  in  
response  to  stretch  has  been  demonstrated  experimentally,  and  the 
abnormal  stretch  of  the  prolapsed  leaflet  may  be  of  pathogenetic 
significance.
Paroxysmal  supraventricular  tachycardia  is  the  most  common 
sustained  tachyarrhythmia  in  patients  with  Mitral  Valve  Prolapse  and  may 
be  related  to  an  increased  incidence  of  left  atrioventricular  bypass  tracts.  
The  incidence  of  Mitral  Valve  Prolapse  among  patients  with  the  Wolff-
Parkinson-White  syndrome  is  increased.  There  is  also  an  increased 
association  between  Mitral  Valve  Prolapse  and  prolongation  of  the  QT 
interval,  and this association may play a role in the pathogenesis of serious 
ventricular  arrhythmias.  Patients  with  Mitral  Valve  Prolapse  have  an 
increased  incidence  of  abnormal  late  potentials  on  signal-averaged 
Electrocardiographs, as well as reduced heart rate variability.
STRESS SCINTIGRAPHY. 
The  differential  diagnosis  between  two  common  conditions—  Mitral 
Valve  Prolapse  associated  with  chest  pain  and  ECG  abnormalities  and 
primary  coronary  artery  disease  associated  with  Mitral  Valve  Prolapse  —
may  be  aided  by  exercise  electrocardiography.  However,  myocardial 
perfusion  scintigraphy  using  thallium-201  or  sestamibi  during 
pharmacological  exercise  stress  is  more  specific  for  diagnosing  associated 
coronary artery disease.
ANGIOGRAPHY
Angiography  is  not  recommended  for  the  diagnostic  evaluation  of 
Mitral  Valve  Prolapse.  However,  if  angiography  is  performed  for  other  
indications,  there  are  features  of  the  left  ventriculogram  that  are 
characteristic  of  Mitral  Valve  Prolapse.  The  right  anterior  oblique 
projection  is  most  useful  for  defining  the  posterior  leaflet  of  the  mitral  
valve,  and  the  left  anterior  oblique  projection  is  most  useful  for  studying 
the  anterior  leaflet.  [20 ] The  most  helpful  sign  is  extension  of  the  mitral 
leaflet  tissue  inferiorly  and  posteriorly  to  the  point  of  attachment  of  the  
mitral  leaflets  to  the  mitral  annulus.  Angiography  may  also  reveal 
scalloped  edges  of  the  leaflets,  reflecting  redundancy  of  tissue.  Other  
angiographic  abnormalities  in  some  patients  with  Mitral  Valve  Prolapse 
include Left  Ventricular dilation,  decreased systolic contraction (especially  
of  the  basal  portion  of  the  ventricle),  and  calcification  of  the  mitral  
annulus.
MAGNETIC  RESONANCE  IMAGING  AND  CARDIAC  COMPUTED 
TOMOGRAPHY. 
These  advanced  imaging  techniques  can  help  in  determining  the 
extent  of  Mitral  Valve  Prolapse  and  Left  Ventricular  function  in  patients  
with  suboptimal  echocardiographic  examinations.  CMR  is  also  useful  for  
evaluating presence and severity of Mitral Regurgitation.
DISEASE COURSE
The  outlook  for  patients  with  Mitral  Valve  Prolapse  in  general  is 
excellent;  large  majorities  remain  asymptomatic  for  many  years  without  
any  change  in  clinical  or  laboratory  findings.  Serious  complications 
(cardiac  death,  need  for  cardiac  surgery,  acute  infective  endocarditis,  or  
cerebral embolic events) occur at a rate of only 1 per 100 patient years, and 
4  percent  of  patients  died  during  the  8  years.  In  contrast,  one  study 
reported  a  much  more  aggressive  course  in  833  patients  with  Mitral  Valve 
Prolapse,  with a 19 percent mortality rate at 10 years and a 20 percent rate  
of  Mitral  Valve  Prolapse  -related  events,  including  heart  failure,  Atrial  
Fibrillation,  Cerebrovascular  events,  arterial  thromboembolism,  and 
endocarditis.  The  apparent  explanation  for  these  latter  observations  is  that  
patients  with  Mitral  Valve  Prolapse  could  be  risk  stratified  on the  basis  of  
several  factors.  The  primary  risk  factors  were  moderate  to  severe  Mitral  
Regurgitation and/or Left Ventricular ejection fraction less than 50 percent,  
and  secondary  risk  factors  included  mild  Mitral  Regurgitation,  left  Atrial  
dimension  40  mm  or  greater,  flail  leaflet,  and  age  50  years  or  older.  
Patients  with  a  primary  risk  factor  had  excessive  mortality  and  morbidity,  
as  did  those  with  two or  more  secondary  risk  factors.  Other  series  support  
these  observations,  demonstrating  greater  risk  of  cardiac  death  or  Mitral  
Valve  Prolapse  -related  complications  in  men,  those  older  than  45  years  
old,  those  with  holosystolic  murmurs,  those  with  severe  Mitral 
Regurgitation,  and  those  with  left  Atrial  dimension  greater  than  40  mm. 
Other  series  that  have  reported  a  lower  prevalence  of  adverse  sequelae  of  
Mitral  Valve  Prolapse  have  included  relatively  fewer  patients  with  these  
risk  factors.  Progressive  Mitral  Regurgitation  with  gradual  increase  in  left  
Atrial  and  Left  Ventricular  size,  Atrial  Fibrillation,  pulmonary 
hypertension,  and  the  development  of  congestive  heart  failure  is  the  most  
frequent  serious  complication,  occurring  in  about  15  percent  of  patients 
over  a  10-  to  15-year  period.  Patients  with  the  Mitral  Valve  Prolapse  
syndrome are also at  risk of developing infective endocarditis.  Both severe  
Mitral  Regurgitation  and  endocarditis  develop  more  frequently  in  patients  
with  both  murmurs  and  clicks  than  in  those  with  an  isolated  click,  in 
patients  with  thickened  (greater  than  5  mm)  and  redundant  mitral  valve 
leaflets,  and  in  men  older  than  50  years  .  In  many  patients,  rupture  of  
chordae tendineae is responsible for the precipitation and/or intensification  
of  the  Mitral  Regurgitation.  Infective  endocarditis  often  aggravates  the 
severity  of  Mitral  Regurgitation  and  therefore  the  need  for  surgical  
treatment.
The  prevalence  of  mitral  valve  prolapse  in  Stickler  syndrome  has 
been reported to be much higher than in the general population. [1 7]
Acute  hemiplegia,  transient  ischemic  attacks,  cerebellar  infarcts,  
amaurosis  fugax,  and  retinal  arteriolar  occlusions  have  been  reported  to 
occur more frequently in patients with the Mitral Valve Prolapse syndrome,  
suggesting  that  cerebral  emboli  are  unusually  common in this  condition.  It  
has  been  proposed  that  these  neurological  complications  are  associated  
with  loss  of  endothelial  continuity  and  tearing  of  the  endocardium 
overlying  the  myxomatous  valve,  which  initiates  platelet  aggregation  and 
the  formation  of  mural  platelet-fibrin  complexes.  Although  it  has  been 
proposed  that  embolization  secondary  to  Mitral  Valve  Prolapse  may  be  a  
significant  cause  for  unexplained  strokes  in  young  people  without 
cerebrovascular  disease,  a  large  case-controlled  study  showed  no 
association  between  Mitral  Valve  Prolapse  and  ischemic  neurological 
events in persons less than 45 years of age.
MITRAL VALVE PROLAPSE AND SUDDEN DEATH
The relation between the Mitral  Valve  Prolapse syndrome and sudden 
death  is  not  clear.  However,  the  best  evidence  suggests  that  Mitral  Valve  
Prolapse  increases  the  risk  of  sudden  death  slightly,  especially  in  patients  
with severe Mitral Regurgitation [1 0] or severe valvular deformity, and those 
with  complex  ventricular  arrhythmias,  QT  interval  prolongation,  and  a 
history of syncope and palpitations.  [ 3 4]
AUTONOMOUS NERVOUS SYSTEM:
It consists of Sympathetic and Parasympathetic Systems.
ANATOMY:
The  autonomic  outflow  is  regulated  by  the  centres  in  Hypothalamus, 
Midbrain, Pons and Medulla.
Sympathetic  outflow is  from T1 to L2.  Preganglionic  fibres are  small  
myelinated  fibres  that  synapse  in  Para  vertebral  ganglia.  Small  
unmyelinated post ganglionic fibres innervate the body organs. 
Parasympathetic  outflow is  Cranio  Sacral  outflow.  Cranial  nerves  are 
3,  7,  9 and 10 and from S2 to S4.  Preganglionic fibres are long myelinated 
fibres that synapse with post ganglionic fibres nearby the viscera.
AUTONOMOUS FUNCTION TESTS:
I. Cardiovascular
1. Resting Heart Rate:
2. Beat to beat variation of Heart Rate:
There  is  variation  in  heart  beat  from  beat  to  beat  by  various 
influences  including  the  depth  of  respiration.  Change  in  Vasomotor  tone 
also matters.
3. Heart Rate variation to deep breathing:
Subject  breaths  deeply  and  heavily  at  a  arte  of  6  breaths  per  minute.  
ECG is  recorded.  Maximum and minimum Heart  Rate  during 10 seconds is 
recorded. Mean of 3 cycles is taken. Normally the difference is >15.
4. Valsalva Manuoevere:
This  test  is  performed  by  asking  the  subject  to  sit  quietly  and  then 
blow  with  mouth  closed.  There  are  4  phases.  The  ratio  of  longest  RR 
interval  shortly  after  Manuoevere  to  shortest  RR  interval  during  the 
Manuoevere  is  measured  and  expressed  as  Valsalva  ratio.  The  mean  of  3  
successive  Valsalva  Manuoeveres  is  taken.  Low  Valsalva  ratio  implies 
parasympathetic abnormality.
5. Postural Hypotension:
Subject  lies  quietly  in  a  couch  for  15  minutes.  Blood  Pressure  is  
recorded  in  supine  position.  Then  Blood  Pressure  is  again  recorded  5 
minutes  after  standing.  Fall  of  systolic  Blood  Pressure  >  30  mmHg  or 
Diastolic  Blood  Pressure  >  15  mmHg  is  abnormal.  This  is  test  for  
Cardiovascular sympathetic efferent and Baroreflex pathway.
6. Postural tachycardiac Index:
During  postural  change  from  lying  to  standing  a  characteristic 
immediate rapid rise in heart rate occurs which is maximal at about the 15 t h 
beat after standing, followed by relative overshoot bradycardia at 30 t h beat, 
Normal ratio is > 1.04 in young adults.
7. Sustained Handgrip test:
Maximum sustained voluntary contraction of  hand muscles is steadily 
maintained,  upto  5  minutes.  Blood  Pressure  is  measured  on  the  non-
exercising  arm 3  times  at  rest  and  1  minute  interval  during  handgrip.  The 
difference  in  Diastolic  Blood Pressure  is  taken.  Normally  there  is  increase 
in 16 mmHg.
8. Atropine Test:
On  injecting  atropine  intravenously  there  is  increase  in  heart  rate;  
normally an increase of 20 beats per minute.
9. Cold pressor test:
Hand is immersed in cold water at 4 0 C for 5 minutes. Blood Pressure, 
Pulse  Rate  is  recorded  and  compared  with  rest.  Normally  there  is  increase  
in  systolic  Blood  Pressure  by  15  –  20  mm  and  diastolic  Blood  Pressure 
increase by 10 – 15 mm.
10. Trinitroglycerine test:
The  Heart  Rate,  Blood  Pressure  of  the  subject  is  taken  before  and 
after  0.6mg  sublingual  Trinitroglycerine.  Blood  Pressure  is  taken  supine 
and standing position. Fall in Blood Pressure is noted.
II. Sudomotor Function Tests:
1. Quantitative  Sudomotor  Axon  Reflex  Test  (QSART)  measures  sweat 
output from skin.
2. Galvanic Skin response.
3. Thermal Sweat Test.
III. Pilomotor Response:
Skin  of  the  subject  at  the  nape  of  neck  is  gently  stroked  with  a  pin.  Time 
taken for development of cutis anserine is noted.
IV. Tests of Lacrimation:
1. Schrimer’s test.
2. Pupil Cycle time.
3. Pupil response to drugs.
V. Gastrointestinal Function tests:
1. Barium Studies.
2. Video cineradiography.
3. Gastric emptying studies.
4. Intraluminal pressure studies.
VI. Tests of Genitourinary Functions.
1. Penile Plethysmography.
2. Intracaval Papavarine.
3. Urodynamic studies.
MITRAL VALVE PROLAPSE AND AUTONOMIC DYSFUNCTIONS:
Many  of  the  clinical  features  of  Mitral  Valve  Prolapse  are  attributed 
to  abnormal  neural  function.  Such  a  dysfunction  has  long  been  suspected 
because  of  stress  related  arrhythmias  and  hyperkinetic  ventricular 
contractions and because of abnormal response to various maneuvers.
Barlow et  al noted high prevalence of anxiety and cognitive disorders 
in  patients  with  Mitral  Valve  Prolapse.  Similar  observations  made  by 
Hancock  et  al  and  Cohn,  who  found  symptoms  of  seemingly 
neuropsychiatric origin.
INNERVATION  OF  MITRAL  VALVES  IN  NORMAL  AND  PROLAPSED 
VALVES:
Immunochemical  tests  were  conducted  both  in  normal  and  prolapsed 
mitral  valves.  Immunochemical  location  of  S  –  100  proteins,  Glial  
Fibrillary  Acid  Protein  (GFAP),  Neurofilament  Protein  (NFP)  were 
examined  to  detect  the  distribution  of  all  nerve  endings,  choline  acetyl  
transferase [ChAT] to detect the distribution of cholinergic nerve fibres and  
Neuropeptide Y and Calcitonin Gene Related Peptide (CGRP) to  detect  the 
distribution  of  nerve  fibres  by  and  in  brush  peroxidase  complex  method.  
The distribution of adrenergic nerve fibres was examined.
In  normal  valve  S  –  100 proteins  was  demonstrated  in  base  and  body  
of  the  cusps.  The  distribution  of  GFAP,  ChAT,  NPY,  CGRP were  found  to 
be as that of S – 100 protein in both normal and prolapsed valves.
PATHOPHYSIOLOGY:
Various studies have shown strong evidence of Autonomic disturbance 
in  patients  with  Mitral  Valve  Prolapse  Syndrome,  probably  involving  both  
sympathetic  and  parasympathetic  systems.  Metabolic  and  neuroendocrine 
abnormalities  in  patients  with  Mitral  Valve  Prolapse  Syndrome  include 
catecholomines,  hyper  response  to  adrenergic  stimulus,  due  to  altered  β 
adrenergic  receptor  coupling  to  adenyl  cyclase,  parasympathetic 
abnormalities,  abnormalities  of  baroreceptor  reflex  modulation,  Renin 
Angiotensin  System,  Atrial  Natriuretic  Factor  secretion,  decreased 
intravascular volume and decreased Left Ventricular volume.
Gaffney et  al  studied Mitral  Valve Prolapse and found that  when they 
were  exposed  to  lower  body  negative  pressures,  they  showed  greater  
decrease  in  forearm blood flow and  a  lesser  increase  in  calf  blood volume  
suggesting  excessive  α  adrenergic  responses.  He  also  performed  ice  water  
immersion to trigger the diving response and demonstrated that the patients  
with Mitral Valve Prolapse had less Bradycardia than Normal persons.
Bo doulas and co workers demonstrated that the mean 24 hour urinary 
excretion  of  Catecholomines  was  significantly  greater  in  Patients  with 
Mitral Valve Prolapse.
Pasternak  demonstrated  significantly  elevated  total  plasma 
Catecholomines  and  plasma  nor  epinephrine  levels  in  all  fifteen 
symptomatic  patients.  They  observed  that  Heart  Rate  was  lower  than  in  
normal  subjects  in  supine  position  but  returned  to  normal  in  upright  
position.  This  observation  suggested  that  increase  in  both  resting 
Sympathetic  and  vagal  tone.  [5 ]  This  observation  of  relative  sinus 
Bradycardia  had variance with data  reported by Decavallo et  al,  Coghan et  
al.  Heart  Rate  And  Blood  Pressure  response  to  Standardized  Valsalva 
maneuver  and  postural  tests  in  41  treated  patients  with  Mitral  Valve 
Prolapse  and  observed  that  Bradycardia  became greater  in  more  prolonged  
after returning to recumbency position.
A proposed pathway for  orthostatic  tolerance in  symptoms in patients 
with Mitral Valve Prolapse is as follows
 Mitral Valve Prolapse
Decreased forward stroke volume
Increased catecholamine release
Increased Heart contractility and vasoconstriction
Chronic vasoconstriction
Decreased blood volume
Decreased ventricular volume and fibre length
Increased degree of prolapse
- FA Gaffney et al, AMJ Cardiology, 1983.
The  common  occurrence  of  ST-T  changes  at  rest  and  during  stress  in  
Mitral  Valve  Prolapse  Syndrome  patients  also  in  consistent  with  concepts 
of Autonomic dysfunction. Several investigators have attempted to look for  
the  presence  of  ST-T abnormalities  with  high  incidence  of  arrhythmias  in  
Mitral  Valve  Prolapse  Syndrome.  Support  for  a  relationship  between 
autonomic dysfunction and arrhythmias in Mitral  Valve Prolapse Syndrome 
may be derived from data of Combs et al.
CLINICAL AND THERAPEUTIC APPLICATIONS:
The  existence  of  hyper  adrenergic  state  associated  with  vagotonic 
state  may  provide  the  pathophysiological  basis  for  the  spectrum  of 
arrhythmias observed in these patients.
Adrenergic  blockade  may  be  indicated  in  symptomatic  patients  with 
Mitral  Valve  Prolapse  Syndrome.  It  may  provide  a  protection  against  life 
threatening  arrhythmias  and  even  against  the  risk  of  sudden  death  which 
may  occur  in  as  many  as  1.4%  of  all  patients  with  arrhythmias.  However  
before  any  Adrenergic  blockade,  the  exact  nature  of  autonomic  defect  in  
individual patients must  be determined to assess whether α or β or both are 
required.
For  e.g.  Propanolol  may  cause  increased  α  adrenergic  activity  and 
depending on whether patients with Mitral Valve Prolapse have increased α  
or β activity, the drug may alleviate or increase the symptoms.
Management:
Patients  with  the  physical  findings  of  Mitral  Valve  Prolapse  (and 
those  without  such  findings  who  have  been  given  the  diagnosis)  should 
undergo  transthoracic  echocardiography.  This  procedure  also  should  be 
performed  in  first-degree  relatives  of  patients  with  Mitral  Valve  Prolapse.  
The  diagnosis  of  Mitral  Valve  Prolapse  requires  definitive 
echocardiographic  findings,  and  over  diagnosis  and  incorrect  “labeling”  
have  been  a  major  problem with  this  condition.  Asymptomatic  patients  (or  
those  whose  principal  complaint  is  anxiety),  with  no  arrhythmias  evident 
on  a  routine  extended  ECG  tracing  and  without  evidence  of  Mitral  
Regurgitation, have an excellent prognosis.  They should be reassured about 
the  favorable  prognosis  and  be  encouraged  to  engage  in  normal  lifestyles,  
but  should  have  follow-up  examinations  every  3  to  5  years.  This  should 
include a two-dimensional echocardiogram and a color flow Doppler study.
Patients  with a  long systolic  murmur may show progression of  Mitral  
Regurgitation  and  should  be  evaluated  more  frequently,  at  intervals  of  
approximately  12  months.  Endocarditis  prophylaxis  is  no  longer 
recommended  routinely  for  patients  with  Mitral  Valve  Prolapse,  including 
those with a systolic murmur and typical echocardiographic findings.
Patients  with  a  history  of  palpitations,  lightheadedness,  dizziness,  or  
syncope or those who have ventricular arrhythmias or QT prolongation on a 
routine  ECG should  undergo  ambulatory  (24-hour)  ECG monitoring and/or  
exercise ECG to detect arrhythmias. Because of the risk, albeit very low, of 
sudden  death,  further  electrophysiologic  studies  may  be  carried  out  to 
characterize  arrhythmias  if  they  exist.  Beta-adrenergic  blockers  are  useful  
in the treatment of palpitations secondary to frequent premature ventricular  
contractions  and  for  self-terminating  episodes  of  supraventricular  
tachycardia.  These  drugs  may  also  be  useful  in  the  treatment  of  chest  
discomfort,  both in  patients  with associated  coronary  artery  disease  and in  
those  with  normal  coronary  vessels  in  whom the  symptoms  may  be  due  to  
regional  ischemia  secondary  to  Mitral  Valve  Prolapse.  Radiofrequency 
ablation of atrioventricular bypass tracts is useful for frequent or prolonged  
episodes of supraventricular tachycardia.
Aspirin  should  be  given  to  patients  with  Mitral  Valve  Prolapse  who 
have  had  a  documented  focal  neurological  event  and  in  whom  no  other  
cause, such as a left Atrial thrombus or Atrial Fibrillation, is apparent.
Patients  with  Mitral  Valve  Prolapse  and  severe  Mitral  Regurgitation 
should  be  treated  similarly  to  other  patients  with  severe  Mitral 
Regurgitation and may require MV surgery. MV repair without replacement 
is  usually  possible.  Therefore  the  threshold  for  surgical  treatment  in  these  
patients  is  lower  than  in  patients  with  Mitral  Regurgitation  in  whom  MV 
replacement  may  be  necessary,  providing  that  patients  are  referred  to  a  
surgical  team  with  established  success  in  MV repair,  as  noted  previously. 
The majority of all MV repairs for Mitral Regurgitation are now carried out  
in  patients  with  Mitral  Valve  Prolapse.  Resection  of  the  most  deformed 
leaflet  segment,  usually  the  middle  scallop  of  the  posterior  leaflet,  and 
insertion  of  an  annuloplasty  ring  to  reduce  the  dilated  annulus  is  the  most  
commonly  employed  procedure. [2 ]  Repair  of  anterior  leaflet  prolapse  is 
more  challenging.  Chordal  transfer  can  sometimes  treat  rupture  of  the 
chordae tendineae to the anterior leaflet  from the posterior  leaflet.  In other  
patients,  shortening  of  the  chordae  tendineae  and/or  papillary  muscle  is  
necessary. The average operative mortality is 2 to 3 percent,  and long-term 
studies  demonstrate  excellent  durability  of  MV  repair  in  the  majority  of  
patients.  However,  Mitral  Regurgitation  recurs  in  a  subset  of  patients,  at  
which point it may be necessary to perform MV replacement.
Coronary  arteriography  is  reasonable  in  patients  with  angina  pectoris  
on  effort  and/or  ischemic  ECG  changes,  and  especially  in  those  with 
abnormalities on a stress myocardial perfusion scans. 
In  one  study,  the  10-year  survival  in  patients  after  mitral  valve 
replacement with biologic or mechanical valve prostheses was compared. It  
was  found  that,  choice  of  biologic  or  mechanical  prosthesis  does  not 
significantly  affect  long-term  patient  survival  after  mitral  valve 
replacement. [19 ]
Treatment  should  take  into  account  both  the  responsiveness  of  
symptoms to medical management and the coronary anatomy.
Although  this  discussion  has  focused  attention  on  complications  of  
the Mitral  Valve Prolapse syndrome,  it  should not  be forgotten that,  on the 
whole, this is a benign condition and that the vast majority of patients with  
this  syndrome  remain  asymptomatic  for  their  entire  lives  and  require,  at  
most, observation every few years and reassurance.  
MATERIALS AND METHODS
INCLUSION CRITERIA
All patients with
- Age 14 - 43
- Mid systolic click
- Late systolic murmur
- Or both
EXCLUSION CRITERIA
- Hypertension
- Diabetes Mellitus
- Coronary Artery Disease
- Congestive Cardiac Failure
- Those on cardio active or neuro active drugs
- Systemic illness
PLACE AND PERIOD: 
This  study  was  done in  Govt.  Stanley  Hospital.  Study was  done 
for a period of 1 year, from September 2007 to august 2008. 100 
cases were taken into the study.
HISTORY AND EXAMINATION
The  patients  who  were  referred  for  cardiac  symptoms,  to  cardiology 
Outpatient  Department,  from  Medical  departments,  are  included  in  the 
study.  Patients  from  14–  43  yrs,  both  males  and  females  were  included.  
People belonging to various socioeconomic classes were included.
 All  patients  were  questioned  for  detailed  history.  In  addition  to 
general symptoms, cardiac symptoms like chest pain, palpitation, dyspnoea,  
syncope,  focal  neurological  deficit  were  carefully  evaluated.  Past  history  
was  taken  regarding  hypertension,  other  congenital  heart  diseases  (Atrial  
Septal  Defect,  etc),  Rheumatic  heart  disease,  syphilis,  congestive  cardiac  
failure.  Treatment  history  like,  surgery,  previous  admissions  and  drugs  
taken for  cardiac illness (e.g.  arrhythmias),  neuro active drugs  were  taken.  
Family  history  mainly  focused  to  assess  the  first  degree  relatives,  with 
symptoms. If the relatives were available, they were also examined.
Next, careful general examination was done to find pectus excavatum, 
carinatum,  scoliosis,  reduced  antero-posterior  diameter,  straight  thoracic 
spine and features of Marfan’s syndrome. Blood pressure was taken in both 
arms,  lying  and  standing  positions  and  with  sustained  handgrip  maneuver.  
All  cases  were  carefully  examined  for  evidence  of  congestive  cardiac 
failure,  associated  anomalies  of  heart,  focal  neurological  deficit,  infective  
endocarditis and arrhythmias.
Auscultation of the heart was performed in lying supine, standing and  
left  lateral  positions.  Other  maneuvers  like  leg  rising,  Valsalva,  after  
isometric  exercise  also  performed.  Efforts  were  taken  to  find  out  the 
presence  of  pulmonary  hypertension,  Atrial  Septal  Defect,  Aortic 
Regurgitation,  Tricuspid Regurgitation,  Dissection,  Aneurysm of Aorta  and 
Hypertrophic Cardiomyopathy.
LABORATORY:
Blood  tests  and  urine  tests  were  done  to  check  for  Diabetes  mellitus  
and  Renal  diseases.  Hemogram to  rule  out  Anemia  was  done.  Chest  X-ray  
PA  view  was  taken  in  all  of  the  patients  to  assess  the  cardiac  size,  
pulmonary  vasculature,  aortic  morphology,  thoracic  anomalies  and  mitral  
annular calcification. A 12 lead ECG was taken to look for ST-T changes, T  
wave  inversions,  VPD,  if  any,  that  can  occur  in  Mitral  Valve  Prolapse  
Syndrome.  Also  ECG  was  taken  after  deep  breathing  at  6  breaths  per 
minute and during Valsalva maneuver to look for autonomic dysfunction, if  
any,  that  is  common in Mitral  Valve Prolapse Syndrome. Echocardiography 
was  done  in  all  cases  to  confirm  the  diagnosis  and  look  which  cusp  are  
involved and associated lesions.  Both M Mode and 2D echo were done.  2D 
echo  was  done  in  all  4  views  mainly  parasternal  long  axis  view. 
Redundancy  of  valve  leaflets,  Left  ventricular  and  Left  Atrial  
measurements,  Main  Pulmonary  Artery  measurements  were  taken.  Other 
valves  like  Tricuspid  and Aortic  were also screened for  any anomalies like  
prolapsed, etc. 100 cases were selected for the study.
BEDSIDE TESTS:
The following tests for autonomic function was also done namely,
1. Postural hypotension: Blood Pressure in lying and standing position
2. Sustained Hand grip:  Blood Pressure during rest  and during sustained 
Hand grip.
3. Postural  tachycardia index: Heart  rate measured at  15 and 30 seconds  
after standing through an ECG
4. Valsalva ratio: ECG during various phases of Valsalva manuere.
5. Heart  rate  variation  during  deep  breathing:  through  ECG  recording 
during deep breathing.
All  the  data  were  recorded  in  the  master  chart  and  the  reports  were 
then taken for analysis.
OBSERVATION AND RESULTS
I. Age wise distribution
Table No: 1
Fig 8. Age wise distribution
0
5
10
15
20
25
30
35
14 - 23 24 - 33 34 - 43
male
female
II. Sex distribution
 Table No: 2
Fig 9. Sex Distribution
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III. Symptoms
Table No: 3
       Fig 10. Symptoms.
IV. Signs:
Table no: 4
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V. BONY ABNORMALITIES:
Table no: 5
Scoliosis 15
Pectus excavatum 1
Straight Back Syndrome 2
Marfanoid Habitus: 56
VI. ECG CHANGES
Table No: 6
ST – T CHANGES 18
Atrial ectopic 1
Atrial Fibrillation 1
SVT 1
VPC 2
RBBB 6
LA/LV ABNORMALITY 4
ERS 8
                  
Fig 11. ECG Changes
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VII. ECHOCARDIOGRAPHY
All cases had Mitral Valve Prolapse 
Thickness of Mitral valve >5mm: 43
Table No: 7
Anterior leaflet 31
Posterior leaflet 76
Both 07
VIII. ASSOCIATED CONDITIONS:
Table No: 8
TVP 1
ASD 4
Takayasu Arteritis 1
IX. COMPLICATIONS
Table No: 9
CCF 10%
IE 1%
STROKE 3%
X. AUTONOMIC FUNCTION STUDIES:
Table No: 10
Postural hypotension (S B P > 30 mm) (A) 5
BP changes to sustained hand grip (DBP< 10mm) (B) 4
Imm HR response to Standing 30:15 ratio (<1.00) (C) 13
Valsalva ratio (<1.20) (D) 2
H R variation to deep breathing (<10 beats) (E) 2
No of patients studied: 100
No of patients with positive studies: 16
Fig : 12
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DISCUSSION
Although the auscultatory  findings  of  Mitral  Valve  Prolapse  has  been 
known  for  a  century,  only  three  decade  have  elapsed  since  wide  spread 
recognition  of   association  of  mid  systolic  clicks  or  late  systolic  murmurs 
or  both  with  clinical  features  including  atypical  chest  pain,  palpitation, 
stroke  and  sudden  death.  The  present  study  was  designed  to  evaluate  the 
clinical  profile  and  association  of  co-existent  autonomic  nervous  system 
dysfunction which is present in a subset of patients.
Out of 100 cases,  56 cases were females and 44 cases were males.  So 
the  disease  is  common  in  females.  It  was  most  common  in  the  young 
females.  29 females  were  found in the  age  group of  14 -  23  years.  59.18% 
were females and 40.81% were males.   In older age groups, it  was common 
in  males.  55.55%  of  males  and  44.44%  of  females  in  34  -  43  age  groups.  
Deveseux et al also observed the same occurrences in men.
Age group analysis in our study revealed that maximum occurrence of  
Mitral  Valve Prolapse was in  the 14 -  23 year  age groups,  with 49 patients  
(49%), followed by 24 – 33 year age group 42 patients (42%).
According to  one  study  done by  Rokicki  et  al,  in  which,  all  67  cases  
were  included  below  the  age  of  20  years,  40  were  girls,  which  comes  to 
59.7% and 27 boys which comes to 40.3%. In our study, in age 14 – 23,  29 
were  females  and  20  were  males.  This  comes  to  59.18%  in  females  and
40.80% in males. 
The incidence  of  Mitral  Valve  Prolapse above 24 is  52.9% in females 
and 47.05% in males.  Familial  occurrence  of  Mitral  Valve  Prolapse  is  very 
uncommon.  But  according  to  Rokicki  et  al,  it  was  20%.  The  same  author 
noticed the associated bony abnormalities in 20% cases. But in our study, it  
was found to be 13.5% of cases. 6.5% less.
Detailed  analysis  of  symptoms  in  our  study  found  that  chest 
discomfort  was  found  in  68%  of  cases,  followed  by  palpitation  in  56%  of  
cases, dyspnea in 12% of cases, syncope in 17% of cases, Giddiness in 15%  
of cases, Fatigue in 10% of cases and neurological deficit in 1% of cases.
Detailed  analysis  of  signs  revealed  that,  66% of  cases  had clicks  and 
murmur  in  54%  of  cases.  Murmurs  were  typed  into  Late  systolic  murmur 
(33),  Midsystolic  (17)  and  Holosystolic  (4).  Clicks  only  were  present  in  
46% of  cases,  murmur  only  in  34% of  cases  and both  murmur  and click  in 
20% of cases.
ECG  analysis  revealed  that  18%  of  cases  had  ST-T  changes,  1%  of 
cases  had  atrial  ectopics,  1%  of  cases  had  atrial  fibrillation,  1%  had 
Supraventricular  Tachycardia,  2%  of  cases  had  Ventricular  Premature 
Complexes,  6% of  cases  had Right  Bundle  Branch Block,  8% of  cases  had 
Early  Repolarisation  changes,  and  4%  of  cases  had  Left  Atrial  /  Left  
Ventricular Abnormality.
Echocardiography  showed  that  all  cases  had  Mitral  Valve  Prolapse.  
Involvement  of  Posterior  leaflet  was  common.  But  7  had  involvement  of  
both leaflets. Associated TVP was present in 1 case.
Associated conditions were also found. ASD was found in 4 cases and 
Takayasu’s  Arteritis  (which  was  proved  by  Aortogram)  was  present  in  1  
case.
Marfanoid  habitus  was  found  in  56  %patients.  Scoliosis  was  present 
in  15  Patients,  Pectus  excavatum in  1  patient  and  Straight  Back  Syndrome 
in 2 patients.
Analysis  of  the  complications  showed  that,  10%  of  cases  had 
Congestive  Cardiac  Failure,  1  % of  cases  had  Infective  Endocarditis,  3  % 
of cases had stroke. 
Analysis  of  Autonomic  Dysfunction  by  bed  side  tests  showed  that 
16%  of  patients  were  found  to  be  affected.  The  Heart  Rate  response  to 
standing  from  sitting  (30:15  ratio)  was  the  most  common  abnormality, 
found  in  13  patients,  Postural  Hypotension  in  5  patients,  Blood  Pressure  
response  to  sustained Hand Grip in  4 patients,  Valsalva  ratio  in  2 patients,  
Heart rate response to deep breathing in 2 patients. 
This  was similar  to  observation  made by Taylor  et  al,  who found that  
Postural  Tachycardia  is  the  most  common  Autonomic  abnormality  in 
Patients  with Mitral  Valve  Prolapse.  Similar  observation was also made by  
Coghlan  et  al,  who  found  that  patients  differed  from  controls  by  widely 
oscillating  heart  rate  during  upright  posture.  Vagal  Innervations  of  heart  
was essential  efferent  pathway in maintaining variation of heart  rate which 
decreases  as  age  advances  due  to  lowered  vagal  tone.  As  most  of  these 
patients were young, the abnormality is unlikely to be age related.  Postural  
hypotension was found in  4 % of  patients.  This  is  a  well  known feature  of  
Autonomic neuropathy. This is due to the decrease in plasma volume during 
change of  posture from lying to  standing.  Gaffeney et  al  demonstrated that 
the  plasma  volume  tends  to  be  low  in  patients  with  Mitral  Valve  Prolapse 
and that is the reason for the exaggerated response.
The role  of  Autonomic scoring as pointed out  by  Ewing in 1986 is  to 
be  established.  This  finding  is  presented  as  an  observation  and  has  to  be  
proved by a case control study with more number of subjects in future.
CONCLUSION
THE PRESENT STUDY INDICATES
1. Out of 100 cases,  56 cases were females and 44 cases were males.  So 
the disease is common in females.
2. The  most  common  symptom  is  Chest  discomfort  followed  by 
Palpitation
3. The most common sign is click followed by Murmur
4. The most common involved valve is Posterior Mitral Leaflet.
5. Isolated  Mitral  Valve  Prolapse  is  the  most  common  presentation  and 
only rarely associated with others like Atrial Septal Defect.
6. The most common ECG abnormality was ST – T changes.
7. Marfanoid Habitus was present in 56 patients.
8. Autonomic  Dysfunction  revealed  by  bedside  tests  was  found  in  16 
patients.  Of  which  Immediate  Heart  Rate  response  to  Standing  30:15 
ratio was the most common abnormality.
Fig 2. Mitral Valve Prolapse
Fig 3. Parasternal long axis view
Fig 4. Myxomatous degeneration of cuspis mitral valve
Fig  5. Floppy Mitral Valve, Severe Bi-leaflet Prolapse
Fig  6. M- mode Mitral Valve Prolapse
Fig 7. Systolic billowing of valve
Fig  8. Transthoracic echocardiographic image mitral valve with mitral 
insufficiency secondary to prolapse
Fig 1. Murmur and click of MVPS
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PROFORMA
Name: Age: Case No:
Occupation: Sex: CD No:
Address: MRD No: Echo No:
Chief Complaints:
Chest Pain – Type
Location
Radiation
Relation To exertion
Palpitation - Regular / Irregular
Breathlessness – Exertional / rest
Fatigue / Syncope/ headache / dizziness
Weakness of limbs
Pas H/o
IE / CVA / TIA / Rheumatic Fever /
RHD / HT / CAD / Anxiety
Family H/o
Sudden Death / MVP
Treatment H/o
Previous admissions / drugs / surgery
General Examination:
Height: Weight: BMI:
Pulse: BP: Standing: Supine:
JVP: Kyphosis / Scoliosis / Both
Marfanoid Features:
Iridodonesis: Wrist Sign:
High Arched Palate: Thumb Sign:
Arm Span / Height Ratio: US/LS Ratio:
CARDIOVASCULAR SYSTEM:
S 1: Soft / Normal / loud
Click: Single / multiple
Murmur: mid / late / holosystolic
Radiation: Y/N
CNS: - ANS: - Bedside Tests:
Heart Rate Response: (ECG)
Postural tachycardia index: 
Valsalva ratio: 
Heart rate variation during deep breathing: 
BP Response:
Postural hypotension:
Sustained Hand grip: 
RS: ABD:
INVESTIGATIONS:
ECG: T Inversion
ST – T changes
QT Prolongation
APD / VPD
Others
Chest X – Ray: CT Ratio
Lung Fields:
Echo Cardiography:
Prolapse AML / PML
Redundancy of leaflets:
MR – No / Trivial / Mild / Mod / Severe
LVD Measurements:
LA Dimensions:
MPA Dimensions:
Other Associted Lesions:
